Here are five key notes:
1. The employers offering insurance plans without copays for prescriptions reported savings and positive return-on-investment, according to the report.
2. Patients who don’t have drug prescription copays follow the physician’s orders exactly but the patients who do have copays are more likely to stray from the medication program.
3. Chronic illness patients don’t always realize the full benefits of treatment because 50 percent of those patients don’t take the medications as prescribed. One reason why they don’t adhere to the program is the copay cost.
4. Even low out-of-pocket costs can lead to drug therapy non-adherence.
5. Geisinger employs a value-based insurance program aimed at making medications available for free to high-risk populations, showing an improvement in care quality and cost-savings.
More articles on physicians:
Mount Sinai Health Partners & Aetna form ACO: 5 things to know
Is big data offering an alternative to evidence-based medicine? 6 highlights
Improving healthcare cybersecurity: 3 steps to take
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
